InteRNA presents data on potential of lead oncology development candidate INT-1B3 in immuno-oncology at the SelectBIO Immuno-Oncology Europe 2019 meeting

31 October, 2019

InteRNA presents data on potential of lead oncology development candidate INT-1B3 in immuno-oncology at the SelectBIO Immuno-Oncology Europe 2019 meeting

Please click here to read InteRNA Poster showing the data

EVENTS

07 October 2021 - 11 October 2021

AACR VIRTUAL INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

25 October 2021 - 28 October 2021

BIO-Europe® Digital

08 November 2021 - 15 November 2021

LSX’s Inv€$tival ShowcaseTM, Online & Physical, London, United Kingdom

16 November 2021 - 19 November 2021

8th China Healthcare Summit, Online & Physical , Shanghai Shi, China

NEWS

25 March, 2020

InteRNA steunt de campagne Innovaties in Oncologie van @Mediaplanet. Leer meer over verschillende innovaties in oncologie zoals immuuntherapieën van thought leaders, zoals Ton Schumacher online of in de New Scientist (24 maart 2020)

31 October, 2019

InteRNA presents data on potential of lead oncology development candidate INT-1B3 in immuno-oncology at the SelectBIO Immuno-Oncology Europe 2019 meeting

31 October, 2019

InteRNA presents data on drug formulation and mode of action of lead oncology development candidate INT-1B3 at the 15th annual OTS meeting

15 May, 2019

InteRNA and UMC Utrecht Publish Preclinical Evidence for Potential of miRNAs in Treatment of Epilepsy

25 March, 2019

InteRNA Appoints Andrea van Elsas, Ph.D. to Scientific Advisory Board

1-5 6-10 11-15 16-20 21-25 26-30 31-35 36-40 41-41